PER percheron therapeutics limited

So from my take on the Webinar the Company is dropping ATL 1102...

  1. 115 Posts.
    lightbulb Created with Sketch. 16
    So from my take on the Webinar the Company is dropping ATL 1102 , but over time we have been advised repeatedly about how the drug has good anti- inflammatory properties that could be applicable in numerous diseases and a potential huge market. It would appear from listening today that Company has decided it will not be continuing down that path for the drug. Was the whole anti-inflammatory story just more spin from the BOD to keep us shareholders hanging in.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.